mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0003 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.0005 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.0005 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.0008 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.0008 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
0.001 |